Portfolio Screener · 8 Analysis Engines

Analyze Your Entire Portfolio at Once — Shariah, Risk & More

100 free credits on signup
Sign Up Now

What the 8-Engine Portfolio Screen Covers

Every portfolio is analyzed across 8 specialized engines — giving you institutional-grade insights in one report.

Shariah Compliance (AAOIFI Standard No. 21)
Risk Analysis (VaR, Beta, Drawdown)
Portfolio Rebalancing Suggestions
Performance Attribution
Fundamental Analysis (Valuation & Growth)
Technical Analysis (Indicators & Trends)
News Sentiment Analysis
Executive Summary & Sector Allocation
Per-Stock Breakdown & Details
PDF Export with Full Report
Sample Preview
Portfolio Screener · Member Report
SUNPHARMA · TCS · BHARTIARTL · POLYCAB · ASIANTILES Analyze Portfolio
5 Stocks
SUCCESS Credit cost: 10 29 Sept 2026

Total Value

₹13,858

Total P&L

-10.6%

Day P&L

₹0

Holdings

5

Portfolio Summary

Total Invested

₹15,500

Current Value

₹13,858

Total P&L

₹-1,642

Return %

-10.6%

Day P&L

₹0

Stocks

5

Sector Allocation

Unknown
59.0%
Technology
14.8%
Healthcare
13.4%
Communication Services
12.9%

Best Performer

BHARTIARTL

BHARTIARTL

+4.9%

Worst Performer

ASIANTILES

ASIANTILES

-97.5%

Shariah Compliance Overview

Total Stocks

5

Compliant

4

Non-Compliant

1

Compliance %

80.0%

Overall Verdict: COMPLIANT

Per-Stock Details

Symbol Company Sector Status Score Market Cap
SUNPHARMA.NS Sun Pharmaceutical Industries Limited Healthcare COMPLIANT 100 ₹4,44,380.79 Cr
TCS.NS Tata Consultancy Services Limited Technology COMPLIANT 100 ₹7,40,405.44 Cr
BHARTIARTL.NS Bharti Airtel Limited Communication Services NON-COMPLIANT 80 ₹11,12,352.7 Cr
POLYCAB.NS Polycab India Limited Industrials COMPLIANT 100 ₹1,22,406.04 Cr
ASIANTILES.NS Asian Granito India Limited Industrials COMPLIANT 100 ₹1,488.9 Cr

Debt/Assets

₹4,627.32 Cr

Cash

₹9,770.51 Cr

Purification %

1.57%

Industry

Drug Manufacturers - Specialty & Generic

Non-Compliant Stocks

BHARTIARTL.NS —

Debt 35.4% >= 30.0%

Risk Metrics

Portfolio Beta

0.21

Max Drawdown

+2.4%

Current Drawdown

+0.0%

Recovery Needed

+2.4%

Value at Risk (VaR)

Daily VaR₹268
Weekly VaR₹599
Monthly VaR₹1,228
Confidence95%

Concentration Risk

Max Single Stock58.6%
Max Single Sector59.0%
HHI Index4001
WarningHIGH

Sector Risk Breakdown

Healthcare
13.4%
Technology
14.8%
Communication Services
12.9%
Unknown
59.0%
Risk Level: HIGH

Rebalancing Actions

HOLD
SUNPHARMA.NS

Healthcare · Current 13.4% → Target 13.4%

Moderate performance (+2.9%)
₹0 +2.9%
HOLD
TCS.NS

Technology · Current 14.8% → Target 15.0%

Moderate performance (+2.3%)
₹32 +2.3%
HOLD
BHARTIARTL.NS

Communication Services · Current 12.9% → Target 12.9%

Moderate performance (+4.9%)
₹0 +4.9%
HOLD
POLYCAB.NS

Unknown · Current 59.0% → Target 59.0%

Moderate performance (+1.6%)
₹0 +1.6%
SELL
ASIANTILES.NS

Unknown · Current 59.0% → Target 59.0%

Loss of 97.5% - consider exiting
₹0 -97.5%

Sector Allocation: Current vs Target

Healthcare
13.4% → 0.0%
Technology
14.8% → 15.0%
Communication Services
12.9% → 0.0%
Unknown
59.0% → 0.0%

Returns Overview

Total Invested

₹15,500

Current Value

₹13,858

Absolute Return

₹-1,642

Return %

-10.6%

Annualized

+0.0%

Performance Contribution by Stock

Symbol Return % Contribution P&L
POLYCAB +1.6% 5.58% ₹126
BHARTIARTL +4.9% 3.68% ₹83
SUNPHARMA +2.9% 2.31% ₹52
TCS +2.3% 2.06% ₹46
ASIANTILES -97.5% -86.38% ₹-1,950

Benchmark Comparison

Portfolio

-10.6%

Nifty 50

+12.0%

Alpha

-22.6%

Fundamental Overview

Portfolio Score

70/100

Verdict

Strong

Per-Stock Fundamentals

Symbol P/E P/B ROE D/E Score Rating
SUNPHARMA 18 4.5 +25.0% 0.5 70 STRONG BUY
TCS 26 2.5 +13.0% 1.3 61 BUY
BHARTIARTL 32 3.5 +29.0% 0.4 72 HOLD
POLYCAB 37 3.5 +14.0% 0.9 69 STRONG BUY
ASIANTILES 41 2.5 +28.0% 1.3 78 STRONG BUY

Technical Overview

Portfolio Technical Score

64/100

Verdict

Neutral

Per-Stock Technicals

Symbol RSI MACD SMA Support Resistance Score
SUNPHARMA 63.0 BUY BELOW ₹1,759 ₹1,945 68
TCS 31.0 SELL BELOW ₹1,944 ₹2,149 56
BHARTIARTL 67.0 BUY BELOW ₹1,694 ₹1,872 60
POLYCAB 52.0 BUY BELOW ₹7,720 ₹8,532 78
ASIANTILES 66.0 BUY ABOVE ₹48 ₹53 56

News Sentiment Overview

Overall Sentiment

NEUTRAL

Sentiment Score

0.06

Stocks Analyzed

5

Per-Stock News & Sentiment

NEUTRAL SUNPHARMA SUNPHARMA Score: 0.00

SUNPHARMA announces expansion plans, stock reacts positively

5 articles 2 positive 2 negative 1 neutral
NEUTRAL TCS TCS Score: 0.14

TCS announces expansion plans, stock reacts positively

5 articles 2 positive 1 negative 2 neutral
NEUTRAL BHARTIARTL BHARTIARTL Score: 0.14

BHARTIARTL announces dividend, yields attractive returns

5 articles 2 positive 1 negative 2 neutral
NEUTRAL POLYCAB POLYCAB Score: -0.14

POLYCAB stock hits 52-week high on strong volumes

5 articles 1 positive 2 negative 2 neutral
NEUTRAL ASIANTILES ASIANTILES Score: 0.14

ASIANTILES faces margin pressure due to raw material costs

5 articles 2 positive 1 negative 2 neutral

Sample member report shown for illustration — figures are sample data, not a current status for these companies. Members can analyze any portfolio of up to 100 stocks and receive the full 8-engine report with PDF export. Create an account to get started →

How It Works

1

Add your holdings

Enter each stock symbol, quantity, and buy price — the screener validates symbols in real time.

2

Run 8 analysis engines

Live market data is pulled and analyzed across Shariah, risk, rebalance, performance, fundamentals, technicals and sentiment.

3

Review insights

Get a comprehensive portfolio report with per-stock details, sector allocation, and actionable rebalancing suggestions — or export as PDF.

Methodology & Disclosure

The portfolio screener pulls live NSE/BSE market data (price, volume, valuation, fundamentals, growth and peers) and runs 8 specialized analysis engines covering Shariah compliance (AAOIFI Standard No. 21), risk metrics (VaR, beta, drawdown, concentration), portfolio rebalancing, performance attribution, fundamental analysis, technical analysis, and news sentiment. Every recommendation is human-reviewed before publication.

Disclaimer: The sample above is illustrative. Results are for information and education only and are not investment advice. Investments in the securities market are subject to market risks; read all related documents carefully before investing. SEBI Registered Research Analyst: INH000027201 | BSE Enlistment Number — 7177.